GalenOps prod · 0.1.0

Patient

SITE007-0077

enrolled Phase III

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)

consented 2025-11-27

SITE007 (JPN)

Adverse events

9

Serious AEs

1

Open data queries

0

Luna dropout signal

—

not on Luna

Adverse events 9

moderate assessed 2026-02-15

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-08-11 (study day 67); relationship: not assessed

mild assessed 2026-02-11

Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-08-07 (study day 63); relationship: not assessed

severe serious assessed 2026-02-08

Grade 3 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-08-04 (study day 60); relationship: not assessed; serious criteria: hospitalization

moderate assessed 2026-01-19

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-15 (study day 40); relationship: not assessed

moderate assessed 2026-01-16

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-07-12 (study day 37); relationship: not assessed

moderate assessed 2026-01-14

Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-07-10 (study day 35); relationship: not assessed

mild assessed 2026-01-08

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-07-04 (study day 29); relationship: not assessed

mild assessed 2026-01-08

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-04 (study day 29); relationship: not assessed

mild assessed 2025-12-28

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-06-23 (study day 18); relationship: not assessed

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users